Medicare Reform Using Part D Model Is Advocacy Priority For PhRMA – Castellani
This article was originally published in The Pink Sheet Daily
For PhRMA, supporting a move toward privatizing Medicare is a tactic that may help avoid the establishment of new price controls in the system, like the often-discussed mandated drug rebates in Part D.
You may also be interested in...
As the presumptive architect of Republican presidential candidate Mitt Romney’s transition plan, former HHS Secretary Mike Leavitt would be a strong proponent for modeling future Medicare Parts A and B reforms on the Part D program.
CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old
CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.
The bill that cleared the House March 21 continues to include creation of an Independent Medicare Advisory Commission with broad powers for implementing cost-cutting measures in Medicare.